PPMD Supports Secretome Therapeutics with $250,000 for Cardiac Cell Therapy Development Parent Project Muscular Dystrophy has invested $250,000 in Secretome Therapeutics to advance cardiac therapy for Duchenne muscular dystrophy. This funding aims to enhance treatment avenues for a critical health issue.

PPMD Supports Secretome Therapeutics with $250,000 for Cardiac Cell Therapy Development #United_States #Washington #PPMD #Secretome #Cardiac_Therapy